Kamada reports nine-month revenue of $152.2M and net income of $21.4M
Kamada's unaudited interim accounts to 30 September 2026 show higher revenue and profit year on year, lower R&D spending and $24.2M in declared dividends.
Kamada Ltd. has published unaudited condensed interim financial statements for the period ended 30 September 2026. Revenue for the third quarter was $52.0M. For the first nine months it reached $152.2M, up from $135.8M a year earlier, a rise of roughly 12%.
Net income for the nine months rose to $21.4M from $16.6M. Proprietary product revenue was $128.1M, which on these figures is around 84% of the nine-month total.
R&D spending fell to $6.7M. Cash stood at $75.3M, and the company declared dividends of $24.2M for the nine months.
The material available to VigiEye was a summary of the filing rather than the full statements, so details such as segment breakdowns, prior-year R&D spending and management commentary are not covered here.
What it means for your team
- Proprietary products account for most of Kamada's reported nine-month revenue, which is relevant to anyone tracking its portfolio.
- R&D spending fell to $6.7M for the nine months; the available summary gives no explanation or prior-year comparison.
- The figures are unaudited interim results, and the full statements should be consulted before they are cited.
Company's press release (SEC filing): Kamada Ltd ↗
Article written by VigiEye from the official source (Kamada Ltd). Claims are the company's own. AI-assisted; check the source before acting.